新华医疗
(600587)
| 流通市值：97.04亿 | | | 总市值：101.74亿 |
| 流通股本：4.45亿 | | | 总股本：4.67亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,188,296,441.67 | 2,365,428,288.65 | 2,598,208,586.33 | 2,716,643,731.86 |
| 应收票据及应收账款 | 1,858,881,428.16 | 1,902,868,084.85 | 1,973,625,482.43 | 1,903,764,175.31 |
| 其中：应收票据 | 164,048,949.42 | 117,943,450.67 | 177,154,704.2 | 175,738,483.79 |
| 应收账款 | 1,694,832,478.74 | 1,784,924,634.18 | 1,796,470,778.23 | 1,728,025,691.52 |
| 应收款项融资 | 98,671,231.73 | 46,339,900.91 | 45,294,426.85 | 43,701,723.97 |
| 预付款项 | 166,717,551.88 | 240,689,759.39 | 273,836,080.76 | 272,126,153.17 |
| 其他应收款合计 | 238,494,581.7 | 271,887,504.39 | 262,011,817.86 | 251,955,565.82 |
| 其中:应收利息 | 923,360.79 | 1,950,196.23 | 1,918,115.83 | 1,011,613.19 |
| 应收股利 | 108,044,119.68 | 118,422,468.5 | 106,661,374.12 | 84,486,740.73 |
| 存货 | 3,555,786,774.42 | 3,415,183,464.39 | 3,162,793,986.19 | 3,080,408,088.29 |
| 合同资产 | 113,785,480.39 | 128,887,706.89 | 125,771,239.57 | 110,129,035.02 |
| 一年内到期的非流动资产 | 38,195,200.13 | 3,348,463.23 | 3,348,463.23 | 3,210,864.18 |
| 其他流动资产 | 95,406,699.87 | 85,940,531.61 | 65,219,786.4 | 59,556,791.9 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 9,454,331,945.33 | 8,569,303,616.32 | 8,635,913,551.83 | 8,547,631,096.39 |
| 非流动资产: | | | | |
| 长期应收款 | 14,782,589.01 | 859,473.96 | 1,252,074.85 | 1,371,320.07 |
| 长期股权投资 | 1,633,724,381.31 | 1,571,930,571.05 | 1,563,897,892.71 | 1,562,991,332.46 |
| 其他权益工具投资 | 42,480,444.89 | 114,403,580.17 | 118,292,252.09 | 119,061,786.14 |
| 其他非流动金融资产 | 111,028,358.61 | 40,711,619.22 | 40,711,619.22 | 40,711,619.22 |
| 投资性房地产 | 313,569,578.7 | 314,177,527.89 | 330,640,818.63 | 316,678,699.46 |
| 固定资产 | 2,217,826,263.46 | 2,226,425,609.34 | 2,140,753,634.93 | 2,164,519,425.07 |
| 在建工程 | 739,968,168.95 | 610,373,637.92 | 522,691,238.19 | 518,038,952.7 |
| 使用权资产 | 55,179,599.32 | 57,984,648.05 | 58,316,459.23 | 60,636,520.12 |
| 无形资产 | 478,057,517.37 | 467,536,046.66 | 470,599,998.52 | 467,566,148.11 |
| 商誉 | 257,264,985.95 | 268,758,873.76 | 268,758,873.76 | 268,758,873.76 |
| 长期待摊费用 | 123,327,959.37 | 125,257,117.58 | 126,096,121.79 | 128,121,834.74 |
| 递延所得税资产 | 115,959,767.75 | 92,184,115.03 | 83,828,056.01 | 84,607,540.25 |
| 其他非流动资产 | 32,828,215.21 | 22,579,487.78 | 40,665,412.75 | 48,809,289.18 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 6,135,997,829.9 | 5,913,182,308.41 | 5,766,504,452.68 | 5,781,873,341.28 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 15,590,329,775.23 | 14,482,485,924.73 | 14,402,418,004.51 | 14,329,504,437.67 |
| 流动负债: | | | | |
| 短期借款 | 851,947,102.23 | 795,103,353.42 | 766,980,778.8 | 892,901,407.45 |
| 应付票据及应付账款 | 2,443,285,698.54 | 2,340,952,426.57 | 2,503,397,834.96 | 2,553,095,851.37 |
| 其中：应付票据 | 291,431,225.42 | 336,118,377.4 | 389,650,228.89 | 498,802,345.76 |
| 应付账款 | 2,151,854,473.12 | 2,004,834,049.17 | 2,113,747,606.07 | 2,054,293,505.61 |
| 合同负债 | 2,336,278,758.11 | 2,195,089,608.6 | 2,177,493,291.38 | 2,136,335,714.54 |
| 应付职工薪酬 | 339,849,042.21 | 229,779,985.56 | 216,906,498.57 | 184,210,634.59 |
| 应交税费 | 93,464,360.95 | 85,867,283.86 | 76,774,970.86 | 72,066,442.66 |
| 其他应付款合计 | 1,001,050,068.32 | 445,397,802.17 | 454,075,394.75 | 458,541,944.45 |
| 应付股利 | 62,539,361.33 | 62,657,311.65 | 62,657,311.65 | 59,234,875.91 |
| 一年内到期的非流动负债 | 51,289,191.25 | 34,007,814.58 | 49,687,792.97 | 72,075,900.74 |
| 其他流动负债 | 400,027,196.7 | 358,784,209.44 | 356,554,354.55 | 391,517,393.2 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 7,517,191,418.31 | 6,484,982,484.2 | 6,601,870,916.84 | 6,760,745,289 |
| 非流动负债: | | | | |
| 长期借款 | 137,797,145.91 | 153,699,589.62 | 130,721,200.46 | 119,266,409.44 |
| 租赁负债 | 37,326,438.31 | 28,773,732.02 | 28,212,229.06 | 30,526,102.24 |
| 长期应付款 | 624,225.72 | 191,546.67 | - | 755,074.85 |
| 预计负债 | 19,850,000 | - | - | 6,400,000 |
| 递延收益 | 61,668,321.87 | 91,519,545.47 | 51,228,454.61 | 52,320,269.98 |
| 递延所得税负债 | 96,036,554.53 | 83,087,509.29 | 87,647,343.23 | 79,269,574.66 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 353,302,686.34 | 357,271,923.07 | 297,809,227.36 | 288,537,431.17 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 7,870,494,104.65 | 6,842,254,407.27 | 6,899,680,144.2 | 7,049,282,720.17 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 466,681,989 | 466,681,989 | 466,874,989 | 466,874,989 |
| 资本公积 | 3,000,148,403 | 2,973,029,992.7 | 2,965,897,238.72 | 2,953,530,567.91 |
| 减:库存股 | 60,283,788 | 60,283,788 | 62,456,968 | 62,456,968 |
| 其他综合收益 | 16,394,293.05 | 21,051,420.71 | 21,051,420.71 | 16,372,394.05 |
| 专项储备 | 28,686,532.25 | 26,173,056.53 | 23,889,042.88 | 22,351,068.61 |
| 盈余公积 | 350,760,570.59 | 297,560,668.62 | 297,560,668.62 | 297,560,668.62 |
| 未分配利润 | 3,516,237,200.55 | 3,496,290,108.12 | 3,376,264,762.48 | 3,184,117,470.92 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,318,625,200.44 | 7,220,503,447.68 | 7,089,081,154.41 | 6,878,350,191.11 |
| 少数股东权益 | 401,210,470.14 | 419,728,069.78 | 413,656,705.9 | 401,871,526.39 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,719,835,670.58 | 7,640,231,517.46 | 7,502,737,860.31 | 7,280,221,717.5 |
| 负债和股东权益合计 | 15,590,329,775.23 | 14,482,485,924.73 | 14,402,418,004.51 | 14,329,504,437.67 |
| 公告日期 | 2024-03-29 | 2023-10-25 | 2023-08-23 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | | | |